AstraZeneca (NYSE: AZN) announced today that the U.S. Food and Drug Administration (FDA) has approved the use of NEXIUM® I.V. (esomeprazole sodium) for Injection for children ages greater than 1 month old for the short-term treatment of gastroesophageal reflux disease (GERD) with erosive esophagitis when oral therapy is not possible or appropriate.1 NEXIUM I.V… Acid [...]
Acid Reflux/GERD
FDA Approves NEXIUM(R) I.V. (Esomeprazole Sodium) For The Treatment Of GERD With Erosive Esophagitis In Pediatric And Adolescent Patients
November 8, 2011
News From The Annals Of Family Medicine, May/June
November 7, 2011
Acid-Suppressing Proton Pump Inhibitors Associated with Fracture Risk A meta-analysis of previous research into an unintended effect of acid suppression medications – some of the most widely used medications in the world – finds evidence that long-term use of proton pump inhibitors, but not H2-receptor antagonists, is associated with increased risk of fracture… Acid Reflux [...]
Advanced Technique For Treating Esophageal Lesions Deemed Safe And Effective In European Endoscopy Journal
November 6, 2011
An increasingly popular technique for removing lesions associated with Barrett’s esophagus has been deemed a safe and effective treatment option in a study of more than 1,000 resections published this month in the European journal Endoscopy… Acid Reflux / GERD News From Medical News Today
Modern Treatments For GERD Effective At Achieving Long-Term Remission For Most Patients
November 4, 2011
In an evaluation of contemporary antireflux therapies for chronic gastroesophageal reflux disease (GERD), most patients who received treatment with either the proton pump inhibitor esomeprazole or laparoscopic antireflux surgery achieved and remained in disease remission for 5 years, according to a study in the May 18 issue of JAMA… Acid Reflux / GERD News From [...]
Chronic Gastroesophageal Reflux Disease – Medication And Surgery Equally Effective
November 3, 2011
Laparoscopic antireflux surgery or taking proton pump inhibitor esomeprazole for chronic GERD (chronic gastroesophageal reflux disease) were both found to result in similar rates of disease remission of five years, researchers from Nantes University, France, reported in JAMA (Journal of the American Medical Association)… Acid Reflux / GERD News From Medical News Today
Homing In On Genetic Signature Of Esophageal Cancer
November 2, 2011
University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes. The study, led by Tony Godfrey, Ph.D., a research associate professor of Surgery at the James P… Acid Reflux / GERD News [...]
First Patient Enrolled And Treated In The U.S. For EndoGastric Solutions’ Randomized Study Of Transoral Incisionless Fundoplication (TIF)
November 1, 2011
EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the first patient has been enrolled and treated in the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial). The RESPECT trial was designed by co-principle investigators Dr. John Hunter, Chairman of Surgery, Oregon Health & Science University, and [...]
Physicians Show Bias When Diagnosing Stomach Problems According To Study
November 1, 2011
Patients who complain of upper gastrointestinal (GI) symptoms often face a diagnosis of either gastroesophageal reflux disease (GERD) or functional dyspepsia. Because the two conditions often overlap, it can be difficult to distinguish between them and diagnose them properly… Acid Reflux / GERD News From Medical News Today
Leftover Embryonic Cells Connect Gastric Reflux And Cancer
November 1, 2011
The ultimate source of some cancers is embryonic cells. Research published in the June 24th Cell, a Cell Press publication, traces the precursor of deadly esophageal cancers to leftover embryonic cells found in all adults. Some people with gastric reflux disease have a greater risk of developing esophageal cancer… Acid Reflux / GERD News From [...]
Pitt Study: Esophageal Cancer Risk Higher In Medically Treated GERD Patients With Fewest Symptoms
October 31, 2011
Medically treated patients with mild or no symptoms of gastroesophageal reflux disease (GERD) are at higher risk for developing esophageal cancer than those with severe GERD symptoms, according to a University of Pittsburgh study published in the current issue of Archives of Surgery… Acid Reflux / GERD News From Medical News Today
